KFC
HHS icon

Klingenstein Fields & Co’s Harte-Hanks HHS Stock Holding History

Klingenstein Fields & Co’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,711
Closed -$233K – 315
2013
Q2 		$233K Buy
+2,711
New +$224K 0.01% 286

Other funds holding HHS

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Klingenstein Fields & Co's HHS Position: Q3 2013 in Review

Klingenstein Fields & Co sold out of Harte-Hanks (HHS) in Q3 2013, closing a stake of 2,711 shares — an estimated $233K sold.

Klingenstein Fields & Co first reported a position in HHS in Q2 2013 and held it in 1 quarter. The position peaked at $233K in Q2 2013. 130 funds tracked by Wall St. Rank hold HHS as of Q3 2013.

  • Klingenstein Fields & Co reported no remaining Harte-Hanks position as of Q3 2013 after selling out during the quarter.
  • Klingenstein Fields & Co sold 2,711 Harte-Hanks shares in Q3 2013, an estimated $233K.
  • Klingenstein Fields & Co first reported a position in Harte-Hanks in Q2 2013 and held it in 1 quarter.
  • Klingenstein Fields & Co's Harte-Hanks position peaked at $233K in Q2 2013.
  • 130 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2013.

Based on Klingenstein Fields & Co's 13F filing for Q3 2013, filed 4 Nov 2013.